SyntheticMR has announced that their quantitative imaging software solution SyMRI has received regulatory approval in Brazil and can now be sold on this market.
“We are ecstatic to bring our SyMRI software to the Brazilian market,” says Kyle Frye, President SyntheticMR Inc. “We know there are many healthcare providers that are excited to utilize our technology to speed up their current workflow and add additional information to aid in upfront diagnosis. To be able to sell within Brazil opens up abundant opportunities for SyntheticMR Inc. It also means that combined with our previous regulatory clearance in Mexico we now have access to some of the largest markets in the Americas.”
SyMRI provides multiple contrast weighted images and quantitative information about the patient in a single 5-6 minute scan, enabling users to speed up their imaging workflow and add objective decision support to their practice.Back To Top
SyntheticMRs SyMRI Software Receives Regulatory Approval in Brazil. Appl Radiol.